CIRCADIAN RHYTHM SLEEP DISORDERS MARKET ANALYSIS

Circadian Rhythm Sleep Disorders MarketSize and Trends

Circadian Rhythm Sleep Disorders Market – Drivers:

• Excessive daytime sleepiness:

The excessive daytime sleepiness can affect the drivers, As per public health, due to sleepiness at wheel (while driving) many road accidents happens. Population who suffers from excessive daytime sleepiness is about 5%.

• Increase in sleep-wake disorders:

As per stated by AJMC, (The center for biosimilar), the prevalence of narcolepsy had increased about 14%, from 38.9 in 2013 to 44.3 in 2016. The OSA increased 41% of prevalence from the study period of 2429 to 3240. This increased prevalence was also observed in other examined sleep disorders.

Furthermore, increasing U.S. FDA approval, announcement of new information or manufacturing capabilities and agreements by market players are expected to boost the circadian rhythm sleep disorder market growth over the forecast period.

For instance, Vanda Pharmaceutical, in December 2020 announced that U.S. Food and Drug Administration (FDA) approved its HETLIOZ capsule and liquid formulations for the diagnosis of children and adults, associated with Smith-Magenis Syndrome (SMS) a development disorder which causes sleep disturbances.

Moreover, in October 2018, Eisai announced that they presented new information for phase II evaluation of Lemborexant, an experimental sleep-wake regulation agent, for the diagnosis of irregular sleep wake rhythm disorder in sufferer patient with mild to moderate Alzheimer’s disease. Alzheimer’s disease data was presented in 11^th Clinical Trials conference in Barcelona, Spain. Including insomnia disorder, Lemborexant is also developed for diagnosis of multiple sleep-wake disorders.